Compliance Corner: Here’s How Stryker Decides Whether To Launch A Device Recall
Executive Summary
Stryker Corp. regulatory expert Ommeed Shahrokh explains the device giant’s decision-making process around product recalls and describes what’s included in recall letters to customers.
You may also be interested in...
Device Giants Stryker And Baxter Embrace A ‘Quality First’ Culture – And Yield Positive Results
From cutting costs to getting products to market faster, experts at the two companies explain why it pays to keep quality at the fore.
FDA Warning Letter Recap, November 2021: 3 Device Makers Cited After On-Site Inspections
Invacare, Smiths Medical and CellEra were cited for quality systems and Medical Device Reporting violations in the only device-related warning letters released by the agency last month.
FDA Preps Device Makers To Use eSTAR For De Novo Requests
Manufacturers can’t use the US FDA’s voluntary eSTAR product submission program for de novo requests until January – but they can start practicing now on how to use eSTAR for that review pathway.